Your SlideShare is downloading. ×
0
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Immunopharmacology
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Immunopharmacology

836

Published on

Published in: Technology
1 Comment
0 Likes
Statistics
Notes
  • Be the first to like this

No Downloads
Views
Total Views
836
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
79
Comments
1
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. IMMUNOPHARMACOLOGY Ma. Janetth B. Serrano, M.D., DPBA
  • 2. IMMUNOPHARMACOLOGY <ul><li>2 major components of the immune system: </li></ul><ul><ul><li>INNATE </li></ul></ul><ul><ul><ul><li>Physical – skin, mucus membrane </li></ul></ul></ul><ul><ul><ul><li>Biochemical – complement, lyzosyme </li></ul></ul></ul><ul><ul><ul><li>Cellular – macrophages, neutrophils </li></ul></ul></ul><ul><ul><li>ADAPTIVE </li></ul></ul><ul><ul><ul><li>Antibodies – HUMORAL immunity </li></ul></ul></ul><ul><ul><ul><li>T-lymphocyte – CELL MEDIATED immunity </li></ul></ul></ul>
  • 3. <ul><li>COMPLEMENTS in Innate Immunity: </li></ul><ul><li>1. C3a, C5a  chemotaxis </li></ul><ul><li>2. C3b  opsonization </li></ul><ul><li>3. C5b, C6, C7, C8, C9  MAC </li></ul>IMMUNOPHARMACOLOGY
  • 4. IMMUNOPHARMACOLOGY 0psonized bacteria Macrophage APC T lymphocyte IL-2 IL-2 IFN-  Activated Macrophage Activated NK cells Activated Cytotoxic T cell CELL-MEDIATED IMMUNITY B lymphocyte IL-4,IL-5 TH 1 TH 2 Memory B Cells <ul><li>Plasma Cells: </li></ul><ul><li>IgG - IgM </li></ul><ul><li>IgA - IgD </li></ul>HUMORAL IMMUNITY IFN-  TNF-  IFN- 
  • 5. <ul><li>T-helper cells: </li></ul><ul><li>1. T H 1 subset </li></ul><ul><li>- IFN-  , IL-2, TNF-  </li></ul><ul><li>2. T H 2 subset </li></ul><ul><li>- IL-4, IL-5, IL-6, IL-10 </li></ul>IMMUNOPHARMACOLOGY
  • 6. <ul><li>ABNORMAL IMMUNE RESPONSES: </li></ul><ul><ul><ul><li>HYPERSENSITIVITY </li></ul></ul></ul><ul><ul><ul><li>AUTOIMMUNITY </li></ul></ul></ul><ul><ul><ul><li>IMMUNODEFICIENCY </li></ul></ul></ul>IMMUNOPHARMACOLOGY
  • 7. <ul><ul><li>1. Corticosteroids </li></ul></ul><ul><ul><li>2. Cyclosporine </li></ul></ul><ul><ul><li>3. Sirolimus </li></ul></ul><ul><ul><li>4. Tacrolimus </li></ul></ul><ul><ul><li>5. Interferons </li></ul></ul><ul><ul><li>6. TNF-alpha binding drugs </li></ul></ul><ul><ul><li>7. Mycophenolate mofetil </li></ul></ul><ul><ul><li>8. 15-Deoxyspergualin </li></ul></ul><ul><ul><li>9. Thalidomide </li></ul></ul><ul><ul><li>10. Glatiramer </li></ul></ul>Immunosuppressants IMMUNOPHARMACOLOGY
  • 8. Corticosteroids IMMUNOPHARMACOLOGY
  • 9. <ul><li>MOA: </li></ul><ul><ul><li>inhibit T-cell proliferation & T-cell dependent immunity </li></ul></ul><ul><ul><li>Inhibit expression of genes encoding cytokines </li></ul></ul><ul><ul><li>Inhibit production of inflammatory mediators </li></ul></ul><ul><li>Affects cell-mediated immunity more than humoral immunity </li></ul>IMMUNOPHARMACOLOGY
  • 10. <ul><li>Continuous administration: </li></ul><ul><ul><li>↑ fractional catabolic rate of IgG </li></ul></ul><ul><li>Indications: </li></ul><ul><ul><li>Autoimmune disorders </li></ul></ul><ul><ul><ul><li>- autoimmune hemolytic anemia, LE </li></ul></ul></ul><ul><ul><ul><li>- ITP, Inflammatory Bowel Dse,, Hashimoto’s </li></ul></ul></ul><ul><ul><li>Modulate allergic reactions - asthma </li></ul></ul><ul><ul><li>Organ transplantation – rejection crisis </li></ul></ul>IMMUNOPHARMACOLOGY
  • 11. <ul><li>Immunosuppressive dose: </li></ul><ul><ul><li>10-100 mg/day </li></ul></ul><ul><li>Adverse effects: </li></ul><ul><ul><li>GI bleeding </li></ul></ul><ul><ul><li>adrenal suppression </li></ul></ul><ul><ul><li>fluid retention </li></ul></ul><ul><ul><li>diabetes </li></ul></ul><ul><ul><li>proximal muscle wasting </li></ul></ul><ul><ul><li>superinfections </li></ul></ul>IMMUNOPHARMACOLOGY
  • 12. Corticosteroids IMMUNOPHARMACOLOGY
  • 13. Cyclosporin IMMUNOPHARMACOLOGY
  • 14. <ul><li>Blocks T-cell activation </li></ul><ul><li>binds to cyclophillin  inhibits calcineurin activity  inhibits gene transcription of IL-2, IL-3, IFN  & other factors </li></ul><ul><li>Most commonly used immunosuppresant for renal transplantation </li></ul><ul><li>Indications: </li></ul><ul><ul><li>transplant rejection (kidney, liver, pancreas, cardiac) </li></ul></ul><ul><ul><li>Autoimmune disorders (uveitis, RA, DM type1) </li></ul></ul><ul><li>Toxicities: </li></ul><ul><ul><li>nephrotoxicity, hyperglycemia, hyperlipidemia, osteoporosis, ↑ hair growth, transient liver dysfunction </li></ul></ul>IMMUNOPHARMACOLOGY
  • 15. Cyclosporin IMMUNOPHARMACOLOGY
  • 16. Tacrolimus IMMUNOPHARMACOLOGY
  • 17. <ul><li>Binds to FK-binding protein  inhibits T-cell activation </li></ul><ul><li>10-100 times more potent than cyclosporine </li></ul><ul><li>Liver & kidney transplant </li></ul><ul><li>Oral or IV : t½ = 9-12 hrs </li></ul><ul><li>Toxicity: </li></ul><ul><ul><li>nephrotoxicity, neurotoxicity, hyperglycemia, GI dysfunction </li></ul></ul>IMMUNOPHARMACOLOGY
  • 18. Tacrolimus IMMUNOPHARMACOLOGY
  • 19. Sirolimus (rapamycin) IMMUNOPHARMACOLOGY
  • 20. <ul><li>Binds also to immunophyllin  blocks the response of T-cell to cytokines </li></ul><ul><li>Potent inhibitor of B-cell proliferation & Ig production </li></ul><ul><li>Indications: </li></ul><ul><ul><li>Kidney & heart allografts </li></ul></ul><ul><ul><li>C syclosporin  psoriasis & uveoretinitis </li></ul></ul>IMMUNOPHARMACOLOGY
  • 21. Sirolimus (rapamycin) IMMUNOPHARMACOLOGY
  • 22. Interferons IMMUNOPHARMACOLOGY
  • 23. <ul><li>Type 1: induced by viral inf. </li></ul><ul><ul><li>IFN-alpha  prod. by leukocytes </li></ul></ul><ul><ul><li>IFN-beta  fibroblasts & epithelial cells </li></ul></ul><ul><li>Type 2: IFN-gamma  produced by activated T-lymphocytes </li></ul><ul><li>Indications: cancer </li></ul><ul><li>IFN-   multiple sclerosis </li></ul><ul><li>IFN-   chronic granulomatous disease </li></ul>IMMUNOPHARMACOLOGY
  • 24. Interferons IMMUNOPHARMACOLOGY
  • 25. TNF- α binding drugs IMMUNOPHARMACOLOGY
  • 26. <ul><li>INFLIXIMAB </li></ul><ul><ul><li>Chimeric IgG1 monoclonal antibody with human region & murine regions </li></ul></ul><ul><ul><li>Suppress generation of cytokines </li></ul></ul><ul><ul><li>Crohn’s disease; RA </li></ul></ul><ul><li>ETANERCEPT </li></ul><ul><ul><li>Chimeric protein with human regiom </li></ul></ul><ul><ul><li>Similar MOA with infliximab but shorter half-life </li></ul></ul><ul><ul><li>RA </li></ul></ul>IMMUNOPHARMACOLOGY
  • 27. TNF- α binding drugs IMMUNOPHARMACOLOGY
  • 28. Mycophenolate Mofetil IMMUNOPHARMACOLOGY
  • 29. <ul><li>Inhibits a series of T & B lymphocyte responses </li></ul><ul><li>Inhibit de novo pathway of purine synthesis </li></ul><ul><li>Renal & heart transplantation </li></ul><ul><li>Mizoribine – inh. nucleotide synthesis PW; kidney transplants </li></ul><ul><li>Brequinar Sodium – inh. de novo pathway of pyrimidine synthesi; cancer & organ transplantation </li></ul>IMMUNOPHARMACOLOGY
  • 30. Mycophenolate Mofetil IMMUNOPHARMACOLOGY
  • 31. 15-Deoxyspergualin IMMUNOPHARMACOLOGY
  • 32. <ul><li>Potent antimonocytic & antilymphocytic effect </li></ul><ul><li>Inhibits T & B lymphocyte response </li></ul><ul><li>Renal transplants; pancreas & heart transplants </li></ul>IMMUNOPHARMACOLOGY
  • 33. 15-Deoxyspergualin IMMUNOPHARMACOLOGY
  • 34. Thalidomide IMMUNOPHARMACOLOGY
  • 35. <ul><li>Sedative drug </li></ul><ul><li>Favors TH2 over TH1 </li></ul><ul><li>Suppress TNF- α production </li></ul><ul><li>Antiangiogenesis action: teratogenicity & anticancer </li></ul><ul><li>Indications </li></ul><ul><ul><li>Erythema nodosum leprosum (skin manifestations of SLE) </li></ul></ul><ul><ul><li>Lung transplantation </li></ul></ul>IMMUNOPHARMACOLOGY
  • 36. Thalidomide IMMUNOPHARMACOLOGY
  • 37. Glatiramer IMMUNOPHARMACOLOGY
  • 38. <ul><li>Relapsing-remitting form of multiple sclerosis </li></ul><ul><li>Subcutaneous injection </li></ul><ul><li>Toxicities: </li></ul><ul><ul><li>Transient post-injection reaction </li></ul></ul>IMMUNOPHARMACOLOGY
  • 39. Glatiramer IMMUNOPHARMACOLOGY
  • 40. <ul><li>1. Azathioprine </li></ul><ul><li>2. Leflunomide </li></ul><ul><li>3. Cyclophosphamide </li></ul>IMMUNOPHARMACOLOGY CYTOTOXIC Agents:
  • 41. Azathioprine IMMUNOPHARMACOLOGY
  • 42. <ul><li>Metabolized to 6-mercaptopurines </li></ul><ul><li>Inhibit purine synthesis  interferes with nucleic acid metabolism  inhibits cellular & humoral responses </li></ul><ul><li>Highly teratogenic </li></ul><ul><li>Well absorbed from GI tract </li></ul>IMMUNOPHARMACOLOGY
  • 43. <ul><li>Renal allograft, AGN, SLE(renal), RA, Crohn’s disease </li></ul><ul><li>Prednisone-resistant antibody-mediated ITP </li></ul><ul><li>Autoimmune hemolytic anemia </li></ul><ul><li>Toxicities: </li></ul><ul><ul><li>Bone marrow suppression </li></ul></ul><ul><ul><li>GI disturbances: N&V, diarrhea </li></ul></ul><ul><ul><li>Skin rashes, drug fever, hepatic dysfunction </li></ul></ul>IMMUNOPHARMACOLOGY
  • 44. Azathioprine IMMUNOPHARMACOLOGY
  • 45. Leflunomide IMMUNOPHARMACOLOGY
  • 46. <ul><li>Prodrug of an inhibitor of pyrimidine synthesis </li></ul><ul><li>Inhibits lymphoid cells </li></ul><ul><li>Orally active </li></ul><ul><li>RA </li></ul><ul><li>Toxicities: </li></ul><ul><ul><li>Headache, nausea & diarrhea </li></ul></ul><ul><ul><li>Hepatic dysfunction, renal impairment </li></ul></ul><ul><li>Teratogenic </li></ul>IMMUNOPHARMACOLOGY
  • 47. Leflunomide IMMUNOPHARMACOLOGY
  • 48. Cyclophosphamide IMMUNOPHARMACOLOGY
  • 49. <ul><li>Most potent immunosuppressive drug </li></ul><ul><li>Destroys proliferating lymphoid cells </li></ul><ul><li>Autoimmune disorders: SLE </li></ul><ul><li>Acquired factor XIII antibodies </li></ul><ul><li>Bleeding syndromes </li></ul><ul><li>Toxicities: </li></ul><ul><ul><li>Pancytopenia, hemorrhagic cystitis </li></ul></ul>IMMUNOPHARMACOLOGY
  • 50. Cyclophosphamide IMMUNOPHARMACOLOGY
  • 51. Antibodies as Immunosuppressive Agents <ul><li>Antilymphocytic antibody </li></ul><ul><li>Immune Globulin IV </li></ul><ul><li>Hyperimmune Immunoglobulins </li></ul><ul><li>Monoclonal Antibodies </li></ul><ul><li>Rh o (D) Immune Globulin Micro-Dose </li></ul><ul><ul><li>Prevention of hemolytic disease of the newborn </li></ul></ul><ul><ul><li>Given to mother within 72 hrs after delivery of an Rh-negative baby </li></ul></ul>IMMUNOPHARMACOLOGY
  • 52. <ul><li>1.Muromonab- CD3 </li></ul><ul><li>2. Palivizumab </li></ul><ul><li>3. Rituxumab </li></ul><ul><li>4.Trastuzumab </li></ul>IMMUNOPHARMACOLOGY MONOCLONAL ANTIBODIES :
  • 53. Muromonab-CD3 IMMUNOPHARMACOLOGY
  • 54. <ul><li>A T-cell specific antibody </li></ul><ul><li>Renal transplantation, heart / renal </li></ul>IMMUNOPHARMACOLOGY Muromonab-CD3
  • 55. Muromonab-CD3 IMMUNOPHARMACOLOGY
  • 56. <ul><li>2. Palivizumab </li></ul><ul><li>3. Rituxumab </li></ul><ul><li>4.Trastuzumab </li></ul>IMMUNOPHARMACOLOGY MONOCLONAL ANTIBODIES :
  • 57. <ul><li>P – RSV </li></ul><ul><li>R – follicular B-cell non-hodgekins lymphma </li></ul><ul><li>T – metastatic breast CA </li></ul>IMMUNOPHARMACOLOGY
  • 58. Interferon-alpha
  • 59. IMMUNOMODULATORS <ul><li>CYTOKINES </li></ul>- hairy cell leukemia - chronic myelogenous leukemia - malignant melanoma - Kaposi’s sarcoma - anticancer  renal cell CA, carcinoid syndrome, T cell leukemia
  • 60. Interferon-alpha
  • 61. IMMUNOMODULATORS <ul><li>CYTOKINES </li></ul>GM-CSF Interferons & IL-2 TNF-alpha Interleukin-2 Interferon-gamma Interferon-beta
  • 62. IMMUNOMODULATORS <ul><li>CYTOKINES </li></ul>Melanoma and Prostate cancer (+) effects in response to Hep B vaccine Malignant melanoma Soft tissue sarcoma of extremities Metastatic renal cell CA Malignant melanoma Chronic granulomatous disease Relapsing type multiple sclerosis
  • 63. IMMUNOMODULATORS <ul><li>CYTOKINES </li></ul>GM-CSF Interferons & IL-2 TNF-alpha Interleukin-2 Interferon-gamma Interferon-beta
  • 64. LEVAMISOLE IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY
  • 65. IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY - antiparasitic agent - potentiate action of fluorouracil in adjuvant therapy of Dukes class C colorectal CA - other uses: > hodgkin’s lymphoma > RA
  • 66. LEVAMISOLE IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY
  • 67. BCG (Bacille-Camille-Guarin) IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY
  • 68. IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY - immunization against tuberculosis - Adjuvant in intravesical therapy for SF bladder CA
  • 69. BCG (Bacille-Camille-Guarin) IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY
  • 70. IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY <ul><li>HIV: </li></ul><ul><li>- Inosiplex </li></ul><ul><li>- Diethylcarbamate (DTC) </li></ul><ul><li>DiGeorge Syndrome of T cell deficiency </li></ul><ul><li>- give THYMOSIN </li></ul>

×